Lakefront Biotherapeutics (LKFT) Asset Utilization Ratio (2016 - 2026)

Lakefront Biotherapeutics (LKFT) has reported Asset Utilization Ratio for 10 consecutive years, with 0.31 the latest figure, recorded in Q1 2026.

• In Q1 2026, Asset Utilization Ratio rose 444.64% year-over-year to 0.31; the TTM figure through Mar 2026 stood at 0.31 (up 444.64% YoY), while the FY2025 annual figure was 0.31, up 377.44% from the prior year.
• Asset Utilization Ratio declined to 0.31 in Q1 2026 per LKFT's latest filing, from 0.32 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.32 in Q4 2025 and bottomed at 0.05 in Q4 2024.
• Historically, Asset Utilization Ratio has averaged 0.12 across 5 years, with a median of 0.07 in 2023.
• Annual changes were most pronounced in 2023 — Asset Utilization Ratio slipped 22.48% — and 2025, when it jumped 516.32%.
• Lakefront Biotherapeutics' Asset Utilization Ratio stood at 0.08 in 2022, then declined by 14.71% to 0.07 in 2023, then dropped by 22.0% to 0.05 in 2024, then soared by 516.32% to 0.32 in 2025, then retreated by 3.67% to 0.31 in 2026.
• Business Quant data shows LKFT's Asset Utilization Ratio at 0.31 in Q1 2026, 0.32 in Q4 2025, and 0.06 in Q3 2025.